348 related articles for article (PubMed ID: 22999027)
1. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey.
Khanna PP; Nuki G; Bardin T; Tausche AK; Forsythe A; Goren A; Vietri J; Khanna D
Health Qual Life Outcomes; 2012 Sep; 10():117. PubMed ID: 22999027
[TBL] [Abstract][Full Text] [Related]
2. Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work Productivity.
Wood R; Fermer S; Ramachandran S; Baumgartner S; Morlock R
J Rheumatol; 2016 Oct; 43(10):1897-1903. PubMed ID: 27036386
[TBL] [Abstract][Full Text] [Related]
3. A Systematic Review of the Economic and Humanistic Burden of Gout.
Shields GE; Beard SM
Pharmacoeconomics; 2015 Oct; 33(10):1029-47. PubMed ID: 25969152
[TBL] [Abstract][Full Text] [Related]
4. Burden of peripheral arterial disease in Europe and the United States: a patient survey.
Marrett E; DiBonaventura Md; Zhang Q
Health Qual Life Outcomes; 2013 Oct; 11():175. PubMed ID: 24148832
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey.
Ding B; DiBonaventura M; Karlsson N; Bergström G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():529-539. PubMed ID: 28223793
[TBL] [Abstract][Full Text] [Related]
6. The effect of gout on health-related quality of life, work productivity, resource use and clinical outcomes among patients with hypertension.
DiBonaventura Md; Andrews LM; Yadao AM; Kahler KH
Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):821-9. PubMed ID: 23252362
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and disability in patients with treatment-failure gout.
Becker MA; Schumacher HR; Benjamin KL; Gorevic P; Greenwald M; Fessel J; Edwards L; Kawata AK; Frank L; Waltrip R; Maroli A; Huang B; ; Sundy JS
J Rheumatol; 2009 May; 36(5):1041-8. PubMed ID: 19332629
[TBL] [Abstract][Full Text] [Related]
8. Gout, flares, and allopurinol use: a population-based study.
Proudman C; Lester SE; Gonzalez-Chica DA; Gill TK; Dalbeth N; Hill CL
Arthritis Res Ther; 2019 May; 21(1):132. PubMed ID: 31151457
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy.
Wu EQ; Forsythe A; Guérin A; Yu AP; Latremouille-Viau D; Tsaneva M
Am J Ther; 2012 Nov; 19(6):e157-66. PubMed ID: 21317625
[TBL] [Abstract][Full Text] [Related]
10. Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout.
Khanna PP; Perez-Ruiz F; Maranian P; Khanna D
Rheumatology (Oxford); 2011 Apr; 50(4):740-5. PubMed ID: 21147824
[TBL] [Abstract][Full Text] [Related]
11. Patient-Reported Lupus Flare Symptoms Are Associated with Worsened Patient Outcomes and Increased Economic Burden.
Katz P; Nelson WW; Daly RP; Topf L; Connolly-Strong E; Reed ML
J Manag Care Spec Pharm; 2020 Mar; 26(3):275-283. PubMed ID: 32105178
[TBL] [Abstract][Full Text] [Related]
12. Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom.
Vo P; Fang J; Bilitou A; Laflamme AK; Gupta S
J Headache Pain; 2018 Sep; 19(1):82. PubMed ID: 30203163
[TBL] [Abstract][Full Text] [Related]
13. The effect of serum urate on gout flares and their associated costs: an administrative claims analysis.
Halpern R; Fuldeore MJ; Mody RR; Patel PA; Mikuls TR
J Clin Rheumatol; 2009 Feb; 15(1):3-7. PubMed ID: 19125135
[TBL] [Abstract][Full Text] [Related]
14. The economic burden of uncontrolled gout: how controlling gout reduces cost.
Flores NM; Nuevo J; Klein AB; Baumgartner S; Morlock R
J Med Econ; 2019 Jan; 22(1):1-6. PubMed ID: 30289009
[TBL] [Abstract][Full Text] [Related]
15. Burden of chronic urticaria relative to psoriasis in five European countries.
Balp MM; Khalil S; Tian H; Gabriel S; Vietri J; Zuberbier T
J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):282-290. PubMed ID: 28898460
[TBL] [Abstract][Full Text] [Related]
16. The burden of chronic obstructive pulmonary disease among employed adults.
DiBonaventura Md; Paulose-Ram R; Su J; McDonald M; Zou KH; Wagner JS; Shah H
Int J Chron Obstruct Pulmon Dis; 2012; 7():211-9. PubMed ID: 22500121
[TBL] [Abstract][Full Text] [Related]
17. Humanistic and economic burden associated with depression in the United States: a cross-sectional survey analysis.
Jain S; Gupta S; Li VW; Suthoff E; Arnaud A
BMC Psychiatry; 2022 Aug; 22(1):542. PubMed ID: 35953786
[TBL] [Abstract][Full Text] [Related]
18. Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey.
Gupta S; Kwan P; Faught E; Tsong W; Forsythe A; Ryvlin P
Epilepsy Behav; 2016 Feb; 55():146-56. PubMed ID: 26773686
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality-of-life, work productivity, and economic burden among patients with Parkinson's disease in Japan.
Yamabe K; Liebert R; Flores N; Pashos C
J Med Econ; 2018 Dec; 21(12):1206-1212. PubMed ID: 30200795
[TBL] [Abstract][Full Text] [Related]
20. The burden of hepatitis C in Europe from the patients' perspective: a survey in 5 countries.
Vietri J; Prajapati G; El Khoury AC
BMC Gastroenterol; 2013 Jan; 13():16. PubMed ID: 23324473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
